StockStory.org on MSN
ResMed (RMD): Buy, sell, or hold post Q3 earnings?
Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11 ...
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on ...
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available ...
SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, ...
36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third of respondents are now ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has ...
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...
NEW DELHI--(BUSINESS WIRE)--ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general ...
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present ...
ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2025 on January 30, 2025, after the stock market closes. Following the release, management ...
11monon MSN
ResMed stock drops despite earnings beat
Investing.com -- Shares of ResMed (NYSE:RMD) fell 6% today, despite the company reporting second-quarter earnings that ...
Acquisition lays foundation to build ResMed's digital sleep medicine portfolio in Germany somnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results